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Meta-analysisPreeclampsia is amultifactorial disease characterized by high blood pressure and proteinuria after the 20thweek
of pregnancy. Preeclampsia is associated with microvasculature ﬁbrin deposition and maternal organ dysfunc-
tion. D-dimer (D-Di) has been used as a marker of production/degradation of ﬁbrin in vivo. D-Di has emerged
as a useful diagnostic tool for thrombotic conditions because its plasma concentration has a high negative predic-
tive value for venous thromboembolism. The aim of this studywas to evaluate publications that assessed plasma
D-Di in preeclampsia and normotensive pregnant subjects to deﬁne its diagnostic value. A total of 194 publica-
tionswere identiﬁed. Following the exclusion process, seven studieswere in accordancewith the pre-deﬁned el-
igibility criteria. This systematic review was performed with methodologic accuracy, including a careful
deﬁnition of preeclampsia and a high sensitivity literature search strategy. Quality of the included studies was
assessed in accordance with widely accepted literature recommendations. Our meta-analysis indicates that in-
creased plasma D-Di is associated with preeclampsia in the third trimester of gestation vs normotensive preg-
nant subjects. These preliminary ﬁndings in this select group of patients clearly highlight the need for
additional comprehensive studies throughout pregnancy, including the establishment of an appropriate
cut-off, in order to fully elucidate the diagnostic/prognostic role of D-Di in preeclampsia.
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Preeclampsia is a multifactorial disease characterized by systolic
blood pressure ≥140 mm Hg or diastolic ≥90 mm Hg at bed rest on
at least two occasions 6 h apart, and proteinuria≥0.3 g/24 h,measured
after the 20th week of pregnancy [1,2]. Symptoms frequently observed
in preeclampsia include headache, blurred vision, and abdominal pain.
The etiology of preeclampsia is unknown and the delivery of placenta
167M.B. Pinheiro et al. / Clinica Chimica Acta 414 (2012) 166–170remains the only known treatment. This disease can progress to
eclampsia (characterized by seizures as a sign of affection of the cere-
bral vessels), syndrome HELLP (hemolysis, elevated liver enzyme, low
platelets) or disseminated intravascular coagulation [2]. Although
some laboratory tests such as platelet count and liver enzymes can be
used to monitor the risk of preeclampsia, the diagnosis established by
blood pressure and proteinuria measurement [2].
Preeclampsia is associated with the deposition of ﬁbrin in micro-
vasculature, which results in placental perfusion compromise, in-
trauterine fetal growth retardation [2] and dysfunction of some
maternal organs [3].
In the early stages of ﬁbrin clot formation, activated thrombin
cleaves ﬁbrinogen, a soluble plasma protein. Molecular polymerization
is observed due to the formation of soluble ﬁbrin,which is subsequently
stabilized by covalent cross-linkingwith factor XIII—producing an insol-
uble ﬁbrin matrix. Degradation is immediately initiated by plasmin,
resulting in a variety of relatively stable dimeric fragments or ﬁbrin deg-
radation products. The smallest fragment, D-dimer (D-Di), is resistant
to plasmin degradation. Therefore, D-Di speciﬁcally reﬂects both ﬁbrin
polymerization and breakdown [4–7].
Plasma D-Di is a well established clinical laboratory marker of this
process in vivo. Additionally, D-Di is a useful diagnostic tool due to its
high negative predictive value for venous thromboembolism [6,8,9].
Several studies have shown increased D-Di in preeclampsia vs nor-
motensive pregnant subjects [10–14]. The aim of this meta-analysis
was to compile and evaluate publications that assessed the D-Di by
enzyme-linked immunosorbent assay (ELISA) to deﬁne its diagnostic
value in preeclampsia.2. Methods
2.1. Data sources and searches
An electronic database search was conducted for four databases
(Medline, Embase, LILACS, and Web of Science) from the earliest re-
cord to August 2010. A sensitive search strategy using controlled vo-
cabulary and free text terms was developed for each database with a
combination of relevant key words such as D-Dimer, preeclampsia,
eclampsia, pregnancy induced hypertension and gestational hyper-
tension (full details of the search strategy are available on-request
from the authors). Citation tracking was performed by manuallyFig. 1. Flow chart illustratingscreening reference lists of eligible studies. Studies included in the re-
view were restricted to English, Spanish and Portuguese languages.
2.2. Study selection
Eligible studies included those that evaluated D-Di by ELISA, consti-
tuted by preeclamptic women and controls (normotensive pregnant).
Preeclampsia was deﬁned as systolic blood pressure ≥140 mm Hg or
diastolic ≥90 mm Hg at bed rest on at least two occasions 6 h apart
and proteinuria≥0.3 g/24 h after the 20thweek of pregnancy [2]. Stud-
ies with inappropriate or unclear deﬁnition of preeclampsia and those
presenting insufﬁcient results were excluded.
The retrieved papers were submitted to a rigorous selection pro-
cess using a standardized protocol applied to papers by three authors
independently. Disagreements were resolved by consensus.
2.3. Data extraction
For each included study, two reviewers independently extracted
data such as study design, preeclampsia deﬁnition, number of pre-
eclamptic and normotensive pregnant women in each study, gesta-
tional age at which blood collection occurred, D-Di concentration
and author's conclusions. Data were adjusted to include only preg-
nant women in the third trimester of gestation.
Quality of the included studies was performed according to the
Newcastle-Ottawa Scale recommendations [15] for nonrandomized
studies in meta-analyses [16] and STROBE guidelines [17]. Five do-
mains were considered: appropriate selection of participants, appro-
priate measurement of variables and outcomes, adequate follow-up
rate, control for confounding via statistical adjustment and the exis-
tence of conﬂict of interest. This approach was designed to provide
an overall quality assessment of the speciﬁc domains associated
with potential source of bias in study ﬁndings and was not designed
to provide a score to each individual study [18].
2.4. Data analysis
D-Di (median and standard deviation or median and ranges) from
the participants (case and control groups) were weighted in a meta-
analysis using a random-effect model and were presented in a quali-
tative description. Statistical analyses were performed using Stata
software version 12.0.the exclusion process.
Table 1
Methodological quality of the included studies.
Study Selection of
participantsa
Appropriate
measurement
of variables and
outcomesb
Response ratec Control for confoundingd Funding/conﬂict of intereste
Cases Controls Case Exposure
Catarino 2008 [20] ? ? ✓ ✓ ✘ ✘ ✓
Dusse 2003 [21] ? ? ✓ ✓ ✘ ✘ ✓
He 1997 [11] ? ? ✓ ✓ ✘ ✘ ✓
Schjtlen 1997 [13] ? ? ✓ ✓ ✘ ✘ ✓
Terao 1991 [14] ? ? ✓ ✓ ✘ ✘ ✓
Bellart 1998 [10] ? ? ✓ ✓ ✘ ✘ ✓
Heilmann 2007 [12] ? ? ✓ ✓ ✘ ✘ ✓
aSelection of participants
Case Controls
Representative sample of the general population = ✓ Representative sample of the general population = ✓
Selected group of users (e.g. nurses, volunteers) = ✘ Selected group of users (e.g. nurses, volunteers) = ✘
Unclear = ? Unclear = ?
bAppropriate measurement of variables and outcomes
Case deﬁnition Exposure deﬁnition
Secure record (e.g. surgical records) = ✓ Objective measurement of exposure status or level = ✓
Structured interview; written self report = ✘ Structured interview; written self report = ✘
Unclear = ? Unclear = ?
cResponse rate
Follow-up rate≥85% or non-participation detailed at each stage = ✓
Follow-up rateb85% or no mention about non-respondents = ✘
Unclear = ?
dControl for confounding
Statistical adjustment: multivariate analysis conducted, with adjustment for potentially confounding factors
Yes =✓; No =✘; Unclear = ?
eFunding/conﬂict of interest
No = ✓; Yes = ✘; Unclear = ?
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but a funnel plot could not be used because the few studies included,
in themeta-analysis, which would lead to a test power without ability
to distinguish chance from real asymmetry [19].Table 2
Descriptive summary of the included studies.
Source Study design and
sample size
Cases characteristics C
Catarino 2008 [20] Cross-sectional
Cases: n=44
Controls: n=42
All preeclamptic pregnancies had blood
collected before delivery (median was
37 weeks). Mean age 29.7±5.3.
N
b
ﬁ
m
h
Dusse 2003 [21] Cross-sectional
Cases: n=43
Controls: n=28
Preeclamptic women had blood samples
collected on the third pregnancy semester
H
b
th
He 1997 [11] Cross-sectional
Cases: n=30
Controls: n=24
Preeclamptic women had blood collected
between the 30th and the 35th week of
gestation.
H
b
a
Schjetlein 1997
[13]
Cross-sectional
Cases: n=200
Controls: n=97
Preeclamptic women had blood collected
between the 27th and the 40th week of
gestation. Mean age 28.0 (range 18–42)
H
b
a
M
Terao 1991 [14] Cross-sectional
Cases: n=13
Controls: n=80
Preeclamptic women had blood collected on
the 34th week of gestation
H
b
o
Bellart 1998 [10] Cross-sectional
Cases: n=12
Controls: n=65
Preeclamptic women had blood collected
between the 28th and the 39th week of
gestation
H
b
a
Heilmann 2007
[12]
Cross-sectional
Cases: n=111
Controls: n=33
Severe preeclamptic women had blood
collected after the 35th week of gestation
H
b
a
PE: preeclampsia; D-Di: D-dimer.3. Results
A total of 194 unique titles were identiﬁed. Following the exclusion
process (Fig. 1), nine studies were in accordance with the pre-deﬁnedontrols characteristics Key ﬁndings
ormal pregnancies diagnosed on
asis of clinical and ultrasound
ndings. They did not receive any
edication to interfere with
emostasis. Mean age 30.4±5.7.
There were not found differences in D-Di levels
between cases (median=488.5 ng/mL) and
controls (median=538.2 ng/mL).
ealth pregnant women had
lood samples collected on the
ird pregnancy semester.
There were not found differences in D-Di levels
between cases (mean=1263.8 ng/mL) and
controls (mean=1146.6 ng/mL).
ealth pregnant women had
lood collected between the 30th
nd the 35th week of gestation.
Cases had increased values of D-Di (median=
315.0 ng/mL) when compared with controls
(median=183.0 ng/mL)
ealth pregnant women had
lood collected between the 27th
nd the 40th week of gestation.
ean age 28.7 (range 21–40)
There was a slight increase of D-Di levels in cases
(mean=1595.0 ng/mL) when compared to
controls (mean=1390.0 ng/mL)
ealth pregnant women had
lood collected on the 33th week
f gestation.
There was a slight increase of D-Di levels in cases
(mean=347.87 ng/mL) when compared to
controls (mean=221.52 ng/mL)
ealth pregnant women had
lood collected between the 29th
nd the 36th week of gestation.
There was an increase of D-Di levels in cases
(median=2090.0 ng/mL) when compared to
controls (median=545.0 ng/mL)
ealth pregnant women had
lood collected between the 31st
nd the 40th week of gestation.
There was a slight increase of D-Di levels in cases
(median=1623.60 ng/mL) when compared to
controls (median=1149.0 ng/mL)
Table 3
Detailed data of D-dimer levels according to group of patient.
Study reference Control group Preeclamptic group
D-Di (ng/mL)
(Mean±SD)
Dusse 2003 [21] 1146.6 (311.2) 1263.8 (411.9)
Schjtlein 1997
[13]
1390.0 (559.0) 1545.0 (849.5)
Terao 1991 [14] 221.52 (179.9) 347.87 (460.5)
D-Di (ng/mL)
(Median)
Catarino 2008
[20]
538.2
(Interquartile range 391.2; 822.8)
448.5
(Interquartile range 313.0; 1091.3)
He 1997 [11] 183.0
(Range 110.0; 340.0)
315.0
(Range 145.0; 1150.0)
Bellart 1998 [10] 545.0
(Interquartile range 225.0)
2090.0
(Interquartile range 1800.0)
Heilmann 2007
[12]
1149.0
(Interquartile range 456.0)
1623.60
(Interquartile range 932.9)
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tion. One study was later excluded because preeclamptic women re-
ceived unusual antihypertensive drugs that could bias results. Seven
studies were suitable for the systematic review.
Included studies consisted of cross-sectional analysis of D-Di in
preeclamptic women and normotensive pregnant (control group).
These studies were published from 1991 to 2008 in a variety of coun-
tries including Norway [13], Portugal [20], Brazil [21], Sweden [11],
Japan [14], Spain [10] and Germany [12]. The methodologic quality
of these studies can be considered poor (Table 1).
3.1. Participants
Participants included 453 preeclamptic women and 368 normo-
tensive pregnant. Participants included pregnant women who had
early or late, mild or severe preeclampsia. Unfortunately, detailed in-
formation regarding each group could not be accurately determined.
Mean age of participants was similar among studies (28–32 years).
Gestational age at the time of blood collection was also comparable
(24th to 40th weeks) (Table 2).
Individually, the studies presented a relevant degree of heteroge-
neity concerning D-Di concentration. Mean values ranged from 222
to 1390 ng/mL and from 348 to 1545 ng/mL in the control andNOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.949)
ID
Schjtein 1997
Terao 1991
Dusse 2003
Study
0-380
Fig. 2. Meta-analysis of the difference in means of D-dimer lepreeclamptic groups, respectively. Median values ranged from 183
to 1149 ng/mL and from 315 to 2090 ng/mL, respectively (Table 3).
Weighting the three studies in a meta-analysis, extracted/converted
the data into median and standard deviation [13,14,21]. Under this ap-
proach, increased D-Di was observed in preeclampsia vs normal con-
trols. Mean overall difference was 135.3 ng/mL (28.4–242.1 ng/mL,
95% CI). There was no evidence of heterogeneity among the studies
(I-squared=0.0%; P=0.95) as presented by forest plot (Fig. 2).
4. Discussion
Despite extensive research, diagnosis of preeclampsia remains a
challenge. Although supplementary tests can aid in suspected pre-
eclampsia, diagnosis is routinely assessed by blood pressure and deter-
mination of urinary protein concentration [2]. The use of blood pressure
measurement is unreliable, given the inﬂuence of body position, physi-
cal exertion and potential psychological complications, i.e., anxiety and
stress [22–24]. Proteinuria is usually assessed by reagent dipsticks in a
randomly collected urine sample. A 24 hour urine sample may provide
more accurate results, but its collection is time consuming. Further-
more, reagent strip analysis can provide false positive results in the
presence of vaginal discharge or if urine is too alkaline or contaminated,
i.e., quaternary ammonium and chlorhexidine [25].135.27 (28.44, 242.10)
WMD (95% CI)
155.00 (-6.98, 316.98)
126.35 (-127.07, 379.77)
117.20 (-54.46, 288.86)
100.00
Weight
43.50
17.77
38.73
%
380
vels in normotensive pregnant and preeclamptic women.
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nosis of preeclampsia is highly necessary in order to aid timely pregnan-
cy intervention. Several laboratory markers have been proposed, but
the reliability of these markers has been questioned. Although plasma
D-Di has high negative predictive value for venous thromboembolism
[6,8,9], its diagnostic value in preeclampsia has not been explored.
A variety of tests has been used for D-Di assessment, including ELISA,
latex-based immunoassays andautomated immunoturbidimetric assays
[26–28]. Because ELISA is a more sensitive assay, we decided to include
only studies that used this methodology. As the hypercoagulable state
increases in pregnancy,we included onlywomen in their third trimester
of gestation.
A limitation of this study was the large inter-assay variation in
D-Di measurement among different commercial kits. Because the
same kit was used for both preeclamptic women and normotensive
pregnant in each study, differences in analytic performance, i.e., pre-
cision, sensitivity, speciﬁcity, linearity were mitigated. The strength of
this meta-analysis would be greatly improved if the eligible primary
studies were more homogeneous regarding participants (preeclamp-
tic women and normotensive pregnant). Our results indicate that
preeclamptic women (following disease manifestation) have in-
creased plasma D-Di, when compared to normotensive pregnant. Un-
fortunately, a large number of studies could not be included due to
inappropriate deﬁnition of preeclampsia, regarding diagnostic proce-
dures. The weighed overall effect showed by meta-analysis reveals
the usefulness of D-Di plasma in preeclampsia. Besides, this test
may also be useful for prognosis outcomes along pregnancy.
Another limitation of this review was our inability to extract data
based on preeclampsia diagnosis, as early or late, mild or severe. As
such, we could not exclude the possibility that speciﬁc characteristics
of these subgroups could partially inﬂuence results. Selection bias
was, however, avoided through use of a comprehensive search strategy
in different databases. Moreover, predeﬁned inclusion criteria were
followed to avoid selection bias based on the particular characteristics
stemming from the assessment of a wide range of studies. Publication
bias was mitigated by searching numerous databases and performing
manually citation tracking. Objective measures to assess publication
bias were not effective given the few number of studies included in
meta-analysis.
In conclusion, this reviewwas conducted with methodologic accu-
racy that included a carefully established deﬁnition of preeclampsia
and a highly sensitive literature search strategy. Methodologic quality
of the included studies was assessed in accordance with widely ac-
cepted literature recommendations. Data analyses indicated a possi-
ble diagnostic role for D-Di levels in preeclampsia, especially in the
third trimester of gestation. These initial ﬁndings clearly highlight
the need for additional comprehensive studies throughout pregnan-
cy, including the establishment of an appropriate cut-off, in order to
fully elucidate the diagnostic/prognostic role of D-Di in preeclampsia.
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